All News

The programme will include the launch of next-generation respiratory inhalers, which will use near-zero Global Warming Potential propellants.

UK pharmaceutical firm AstraZeneca has committed to launching its next-generation asthma and chronic pulmonary disease inhaler with near-zero carbon propellants by 2025.

A manifesto making recommendations on how to improve the uptake of vaccines and raise awareness of immunization among European has been presented to the European Commission.

The $470 million investment will support a state-of-the-art facility that produces injectable products and delivery devices.

The International Organization for Standardization (ISO) has published a new standard, named ISO 19577:2019 Critical substances potentially present in footwear and footwear components -- Determination of Nitrosamines.

No need to draw blood; researchers develop smart technology to diagnose diabetes and treat diabetic retinopathy.

The company targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system.

Quality laboratory data is vital to your pharmaceutical development program.

Sai Life Sciences will be in Tokyo for CPHI Japan 2020 during March 16-18, 2020. Please visit booth # 1C - 50 and explore opportunities for collaboration. To schedule an appointment, email [email protected].

Since 2018, oral dosage CDMO Skyepharma radically updated and expanded its packaging capabilities, opening new packaging lines equipped for serialization and aggregation.

In this exclusive interview, CURE Pharmaceutical COO Jessica Rousset explains her company’s dual pharmaceutical/nutraceutical approach and why the cannabinoid space is ripe for drug delivery innovation

The potential acquisition will see UK CDMO NextPharma develop and broaden its technology offering into lipid-based finished dosage forms

First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities.

Business to focus on intelligent and sustainable technologies.

BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program.

GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma

The French National Agency for Medicines and Health Product Safety (ANSM) has agreed that Innate Pharma’s Tellomak (lacutamab) Phase II trial can resume recruitment of new patients with relapsed/refractory Sézary syndrome and mycosis fungoides (MF) in ...

PF-05251749 complements the company’s pipeline of potential disease-modifying therapies for Alzheimer’s and Parkinson’s diseases.

Multiple options provide increased flexibility for sponsors.

Biopharma’s desire for fast, cheap production and cell and gene therapy firms’ need for consistency is shaping tech development in the sector.

The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products.

India’s Lupin Pharmaceuticals warned Monday it could face regulatory sanctions from the US Food and Drug Administration over its Tarapur active pharmaceutical ingredient (API) manufacturing facility.

Dr. Mark Bittinger has joined Sai Life Sciences as Vice President and Global Head of Biology. Mark will be based out of companys' new Discovery Biology facility in Cambridge, Massachusetts, USA, which provides exploratory biology capabilities to the...

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), announced the appointment of Jay Stella as Chief Business Officer, to lead the overall business development and program management for t...

CPHI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPHI, including CPHI North America—the only event to bring the entire North American pharmac...

Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis, and the advancement of regenerative medicine.

The US arm of generic and specialty pharma company Mylan Pharmaceuticals has recalled three lots of its heartburn drug Nizatidine in capsule form amid fears of possible nitrosamine contamination.

Includes:
* Spray pattern
* Plume geometry
* Droplet size distribution

Other tests:
* Priming and Repriming
* Dosage
* Dose uniformity

End-to-end robotic platform provides biotechnology companies, pharmaceutical corporations and academic centres with cost-effective and reproducible drug discovery data.

VAV Life Sciences has inaugurated its cGMP compliant phospholipid manufacturing plant in Mirjole, Ratnagiri, Maharashtra.

Expands company's capacity and capability for this novel modality, providing a one-stop shop from preclinical to commercial.

Drug industry expectations of packaging are evolving with developers now seeking techs that help patients get more from their medicines.

Mutations in the RIPK1 gene responsible for CRIA syndrome.

Capacity to serve global late-stage development and commercial manufacturing of monoclonal antibody drug substance to support new product launches.

Collaboration discovers potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases.

Acquisition adds talent and proprietary therapeutic platform to accelerate next-generation cancer immunotherapy.

Botox and Botox Cosmetic (onabotulinumtoxinA) hold 14 therapeutic and aesthetic indications combined, more than any other neurotoxin in the world.

Next-generation pharmaceutical supply-chain security for tracking product from plant to patient.

Customers and partners look set to benefit from reduced development times and costs of medical drugs.

We asked ten industry experts for their thoughts on some of the emerging trends for the pharmaceutical supply chain as the industry enters 2020...

The investment enhances the supply chain robustness of products manufactured for the makers of solid oral dosage products.

Experts suggest the continued goal of aligning India to Western regulatory standards will help the country sustain significant increases in exports.

CMO's customer base has grown by more than 25% in 2019 alone, and investment and demand for services is estimated to increase output by another 25-30% in 2020.

The past 12 months have been busy as many companies fought to comply with serialization regulations.

Represents the first biopackaging of its kind made of renewable raw materials.

The Chemical & Engineering News, arguably the world's most comprehensive and authoritative news source about chemistry and related fields, featured Sai Life Sciences in its report covering CPHI Worldwide 2019.

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced Sai Nxt, an organization-wide initiative aimed at transforming the company into a new generation CDMO.

NEI-led study to test safety of treatment for a form of age-related macular degeneration that currently lacks treatment.

New CTSuccess service helps to reduce the risk of delays and budget overspend.

The fast-dispersing Zydis formulation could increase compliance with Medication-Assisted Treatment and thus better clinical outcomes.

Smart tags on pills set to improve supply chain security and patient adherence.

The US pharmaceutical industry continues to lead its global peers in terms of innovation and competitiveness, while still ranking high in overall growth potential despite its mature status, according to the results of a survey of 350 global pharmaceuti...

Installation of a SprayVIEW system will help the CDMO to support customers in both innovative and generic inhalation and nasal product development.

Phosphorus trichloride (PCl3) and phosphorus oxychloride (POCl3) are raw materials used on a large scale during the synthesis of pharmaceuticals. They are used for both the production of Active Pharmaceutical Ingredients (API) and intermediates of thos...

Lead asset THOR-707 being explored across multiple solid tumor types alone and in combination with immune checkpoint inhibitors and other future IO combinations.

Expansion increases capacity for the company's topical and transdermal services, as well as dedicated innovation, microbiology and histology laboratories.

Borealis and Borouge announce the launch of a new service solution.

Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges.

New innovation has considerable potential to be used as a new environmentally friendly matrix for the microencapsulation and controlled release of a wide range of actives.

Lilly Gateway Labs will provide biotech companies direct access to Lilly scientists and expertise.

Unprecedented levels of investment cited as a major force driving the expansion.

The financial backing will help the company to develop a new generation of microbial air monitors that enables continuous monitoring as demanded by the Annex 1 revision.

ClearMixx performs liquid/liquid and powder/liquid mixing, with a dispersion plate able to efficiently mix the most challenging buffer, media and biopharmaceutical ingredients.

Content sessions identify value-added medicines, preventive drugs, early diagnostics and patient experience as some of the trends for the year ahead.

The largest area of growth has been within biotechnology companies, where job openings increased by 35%.

The company's diabetes nutrition drink, Celevida, is formulated to help manage blood glucose levels.

The rise in exports growth potential is believed to be in response to concerted reforms by the CDSCO and industry quality improvements in the last few years.

Robinson Brothers is pleased to announce that Jamie Wilkes, Pilot Plant Technician, has been awarded Young Apprentice of the Year as part of the prestigious Black Country Chamber of Commerce Awards 2019.

Company's multimillion euro investment will enable it to meet growing market demands from clients providing cancer treatments.

The new center will provide expertise in critical analytical processes and specialized workflows.

The device's blister is designed to provide flexibility to pharmaceutical partners delivering a wide range of inhaled drugs for both acute and chronic respiratory treatments.

The CDMO offers to acquire Consort Medical to become a Top Five global CDMO player.

Marks the latest step in the company’s ongoing efforts to engage with other organisations working to tackle antimicrobial resistance.

New models can help researchers investigate disease development and find new treatment approaches.

The device supports the new EU GMP Annex 1 requirements.

We are the major player with excellent expertise in manufacturing of ORNIDAZOLE, IRON SUCROSE, MEFENAMIC ACID, FLUCONAZOLE, GLIMEPIRIDE, TIZANIDINE, DFTA, Α-KETOANALOGUES TO ISOLEUCINE/LEUCINE/PHENYLALANINE/VALINE/METHIONINE, TOLFENAMIC ACID, BENFOTIAM...

China-US trade challenges has led to de-risking by pharma companies.

Companies and individuals from across the whole pharma supply chain recognised for their excellence and commitment.

Kappa Bioscience, maker of K2VITAL® vitamin K2-7, will co-exhibit at CPHI in Delhi Nov 26-28 alongside distributor S. A. Pharmachem Pvt. Ltd. of Mumbai. These companies announced a first-of-its-kind drug import license for vitamin K2 in India at CPHI18...

But personalized medicines will require new logistics and manufacturing systems.

Partnership will combine capabilities and expertise in Europe and India to build a new facility dedicated to injectable formulations to supply demand from Europe and overseas territories.

Accuprec Research Labs Pvt. Ltdhas successfully doneMethod Development, Verification & Validation of NDMA impurities in Ranitidine through LCMS/MS [API & Finished Dosage Form] as per USFDA method.

Good blisters only

CAM are glad to announce that a new seat for Campak India is now open. Campak India is the company responsible for the marketing and technical support for all CAM m

Backed by an experienced team, we are able to consistently deliver high quality Vertical Dehumidifier. The equipment made available in this range is appropriate for high humidity areas approximately 2000 – 4000 cu. These dehumidifiers are por...

Demand for biological manufacturing is growing faster than capacity growth.

SAP FILTERS PVT LTD has made a mark in manufacturing and exporting a spectrum of filtration equipment. Its product range is renowned for its quality and durability.

Supreem Pharmaceuticals Mysore Pvt. Ltd. has been selected among the top 100 SME companies in India by Ministry of MSME.

Ultra Fine Mill (Screenless Equipment) are precisely built for grinding of soft to medium hard materials into amazingly fine powder.

Company to reach 250 employees by year end to meet growing drug product manufacturing demand.

Company's strategic move reflects its expectation of short-run aseptic liquid filling to continue to drive pharmaceutical growth.

A shortage of qualified personnel may be a drag factor in cell and gene therapies; in China 100,00L of capacity will need to be added every year to meet bio demand.

GLOBELA PHARMA PVT LTD is coming up new manufacturing facility which is in compliance with MHRA, EU-GMP and PIC/s to cater its services to regulated markets with a big basket of products like Effervescents, Pellets, Tablets, Capsules and Dry Powder Sus...

Dr. Kiran C. Badgujar, Founder and  Director, Mack Pharmatech Pvt Ltd. While discussing the current scenario of SMEs in the country, he lays down the ground rules for further growth of this segment.

Mack Pharmatech is a Nashik-based leading manufacturer of pharmaceutical and laboratory equipment for the past years.

Services including method development, method validation, and stability program design and implementation.

15,000 sq. ft of laboratory and office space will enable continued growth and development of the company’s integrated desktop platform for DNA synthesis.

SWAM PNEUMATICS, a large engineering group company at NOIDA since 1980 and we are leaders in Air-Gas Conveying, Boosting and Vacuum Technology.

Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) has significantly increased its solid dosage form capabilities following a strategic investment in a new state-of the-art tablet coater.

Free webinar to discuss the benefits of a collaborative approach to implementing an electronic batch record platform.

Hovione continues to lead in Spray Drying, thanks to the largest capacity, the most experienced team of scientists that keep coming up with innovative solutions and the best-scale up science.

CDMO to invest over €3 million in GMP facility expansion.

The investment will allow the CDMO to take on new projects, as well as bolster the company's chemistry development capabilities.

The EU security system for prescription medicines was launched on 9 February 2019, accompanied by many discussions: the deadline for implementing the EU Anti-Counterfeiting Directive. The pharmaceutical logistics company Med-X-Press was well prepar...

It is a pleasure to announce that Inden Pharma Packaging has come to an agreement with Medisize Switzerland, where Inden Pharma acquires moulds, machines and equipment for the production of the following Primary Packaging materials: Ophthalmic and...

Prevent Contamination use SS316 Tools - Suitable for FDA/GMP Compliant Sterile /Injectibles/Aseptic Areas

Prevent Fire Hazards use QTi Copper Titanium Non Sparking Safety Tools:

Nordson EFD, a Nordson company (NASDAQ: NDSN) and the world’s leading precision fluid dispensing systems manufacturer, announces its entry into a new market with the introduction of a comprehensive line of disposable dosing syringes for animal health p...

Utopia believes that people are the ultimate foundation of Utopia performance

2008 is the starting of Utopia bussiness in the Egyptian market

Grace, built on talent, technology and trust, is a premier specialty chemicals that provide innovative products, technologies and services that support pharmaceutical development and manufacturing.

Sinocompound are going to take part in the "CPHI Worldwide 2019", held in Frankfurt, Germany in from 5-7 November 2019, and welcome you to visit us. Booth number: 10.1C21.

Sinocompound are going to take part in the "CPHI India 2019", held in Delhi, India in from 26-28 November 2019, and welcome you to visit us. Booth number: 2.C27.

The 15th anniversary of Jiuding factory is in Sanya at SEP 2018.

Beijing Neuronbc will attend 2019 Germany CPHI/P-MEC exhibition in Frankfurt, this is the first time for Beijing Neuronbc to attend.

The European Medicines Agency (EMA) requests Marketing Authorization Holders to perform a Risk Assessment for the presence of Nitrosamines in all Chemically Synthesized API’s.

Germany establishes itself as Europe's leading pharma market in 2019.

The new development by Crystal Automation having "V" blender with intensifier bar  with Powder Transfer System, online Metal Detector for loading of solid ingredients included with online loadcell weighing and batching system.

Rousselot Biomedical, Booth 120D21, CPHI BioProduction, 5 - 7 November 2019Rousselot, the leading global manufacturer of collagen-based solutions, will attend this year’ s CPHI at the BioProduction area.

Union Plastic has developed a new range of APPLISIL® single-dose tubes 1ml & 5ml for multiple applications in Human and Animal health.